Article preview from Medtech Insight - May, 2012
The market for aesthetic laser technology has been growing in the past few years, as the public searches for the perfect combination of low-priced, minimally invasive treatments that promise to restore a more youthful appearance. Dermatologists are the key medical practitioners in this field, and although many physicians have been happy to add new, revenue-producing therapies, the lack of extensive clinical data - particularly in the area of laser-liposuction - is a source of concern for a number of doctors.
Dermatologists See Expanding Role For Energy-Based Treatments
Article preview from Medtech Insight - May, 2012
Despite the uncertain pace of economic recovery, the aesthetics market has a distinct advantage over other fields: the public’s seemingly insatiable quest for youth. Although the struggling economy has taken a toll on certain aesthetic procedures, consumers are still looking for reasonably priced treatments, and that has hastened a move toward less-invasive procedures, especially laser-based therapies. Not surprisingly, dermatologists, who have utilized lasers and other light source technologies for years, are playing a central role in the reshaping market.
As was apparent at the American Academy of Dermatology(AAD) 70th Annual Meeting, held in San Diego in March, interest in laser technology is growing beyond the established use for hair removal, skin conditions, and rejuvenation and is moving into alternative areas such as hair loss, nail fungus, and cellulite. However, many dermatologists caution that some of these new treatment areas still need more scientific data before the expanded uses of lasers can be considered appropriate, mainstream therapies. Despite those concerns, it is clear the market for lasers is growing with a number of new products and therapies entering the field very recently.
Currently, five manufacturers lead this highly populated market with a total of more than $578 million in sales for products and services in 2011, up from $489 million in 2010, according to company filings with the Securities and Exchange Commission.
Continued...
To read this article in its entirety, purchase now as a PDF and receive it immediately via email. Or get it FREE when you subscribe to Medtech Insight Newsletter.
About Medtech Insight
Medtech Insight newsletter provides insights into the technology and market developments (devices, instrumentation, biomaterials, gene therapy, tissue engineering, etc.) impacting a wide range of surgical and non-surgical clinical practices.






Comments